Publications by authors named "Abdallah Kotkat"
Background: Nasopharyngeal carcinoma (NPC) is a rare but significant public health concern, especially in Africa, with a rising global incidence. This study aimed to investigate the pattern of presentation, treatment outcomes and impact on health-related quality of life (HRQOL) of NPC patients at a tertiary institution in Lagos, Nigeria.
Methodology: A retrospective review of all nasopharyngeal cancer patients ( = 125) treated at a tertiary centre in Lagos, Nigeria, from May 2019 to 2022 was done.
To explore the association between COVID-19-related cancer treatment cancellations and the psychological health of cancer patients in Nigeria. We analyzed data collected from 15 outpatient cancer clinics, comprising 1,097 patients between April to July 2020. Study outcome was ten psychological impacts, including feeling down, stressed, and unable to access treatment due to COVID-19 (used as continuous and categorical variable (0-3,4-7,8+ events).
View Article and Find Full Text PDFArticle Synopsis
- - The study investigated how COVID-19 impacted telehealth for cancer patients in Nigeria, analyzing data from over 1,000 patients across 15 outpatient clinics between April and July 2020.
- - Findings revealed that 12.6% of patients had their routine follow-ups changed to virtual visits, with significant associations found among those who had surgical and treatment delays or less frequent interactions with healthcare providers.
- - The conclusion highlighted the increased reliance on virtual care during the pandemic, particularly among patients facing treatment disruptions, emphasizing the need for ongoing research into teleoncology in Nigeria.
Purpose: The purpose of this study is to determine radiotherapy (RT) dose-volumetric threshold of radiation-induced hypothyroidism (HT) in head and neck squamous cell carcinoma (HNSCC) patients.
Patients And Methods: The diagnosis of HT in 78 HNSCC patients treated with RT was based on a thyroid stimulating hormone (TSH) level greater than the maximum value of laboratory range. In all patients, dose-volumetric parameters were analyzed according to their relation to development of HT, and thyroid volumes spared from doses ≥10, 20, 30, 40 and 50 Gy (V10, V20, V30, V40 and V50) were analyzed from the dose volume histograms (DVHs).